Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions

Annals of Neurology

Volumn 75, Issue 6, 2014, Pages 810-828

  Schirmer, Lucas ^a   Srivastava, Rajneesh ^a   Kalluri, Sudhakar Reddy ^a   Böttinger, Susanne ^a   Herwerth, Marina ^a   Carassiti, Daniele ^b   Srivastava, Barkha ^c   Gempt, Jens ^a   Schlegel, Jürgen ^d   Kuhlmann, Tanja ^e   Korn, Thomas ^a,f   Reynolds, Richard ^b   Hemmer, Bernhard ^a,f  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f Institute of Neuropathology University Hospital Münster ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 47; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; GAP JUNCTION PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL POTASSIUM CHANNEL KIR4.1; IMMUNOGLOBULIN G; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIA CELL; GRAY MATTER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; VERY ELDERLY; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AQUAPORIN 4; BRAIN; CELL DEATH; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN G; LEUKOENCEPHALOPATHIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN PROTEINS; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; NEUROGLIA; PHAGOCYTES; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 84903731417     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24168     Document Type: Article

References (58)

1. Krumbholz M, Derfuss T, Hohlfeld R, Meinl E,. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 2012; 8: 613-623.
2. McLaughlin KA, Wucherpfennig KW,. B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv Immunol 2008; 98: 121-149.
3. Schirmer L, Srivastava R, Hemmer B,. To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis. Mult Scler 2014; 20: 271-279.
4. Barnett MH, Prineas JW,. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004; 55: 458-468.
5. Frohman EM, Racke MK, Raine CS,. Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 2006; 354: 942-955.
6. Lassmann H, Bruck W, Lucchinetti CF,. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007; 17: 210-218.
7. Srivastava R, Aslam M, Kalluri SR, et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012; 367: 115-123.
8. Takumi T, Ishii T, Horio Y, et al. A novel ATP-dependent inward rectifier potassium channel expressed predominantly in glial cells. J Biol Chem 1995; 270: 16339-16346.
9. Neusch C, Rozengurt N, Jacobs RE, et al. Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J Neurosci 2001; 21: 5429-5438.
10. Kalsi AS, Greenwood K, Wilkin G, Butt AM,. Kir4.1 expression by astrocytes and oligodendrocytes in CNS white matter: a developmental study in the rat optic nerve. J Anat 2004; 204: 475-485.
11. Poopalasundaram S, Knott C, Shamotienko OG, et al. Glial heterogeneity in expression of the inwardly rectifying K(+) channel, Kir4.1, in adult rat CNS. Glia 2000; 30: 362-372.
12. Djukic B, Casper KB, Philpot BD, et al. Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J Neurosci 2007; 27: 11354-11365.
13. Ishii M, Fujita A, Iwai K, et al. Differential expression and distribution of Kir5.1 and Kir4.1 inwardly rectifying K+ channels in retina. Am J Physiol Cell Physiol 2003; 285: C260-C267.
14. Higashi K, Fujita A, Inanobe A, et al. An inwardly rectifying K(+) channel, Kir4.1, expressed in astrocytes surrounds synapses and blood vessels in brain. Am J Physiol Cell Physiol 2001; 281: C922-C931.
15. Tang X, Taniguchi K, Kofuji P,. Heterogeneity of Kir4.1 channel expression in glia revealed by mouse transgenesis. Glia 2009; 57: 1706-1715.
16. Hibino H, Fujita A, Iwai K, et al. Differential assembly of inwardly rectifying K+ channel subunits, Kir4.1 and Kir5.1, in brain astrocytes. J Biol Chem 2004; 279: 44065-44073.
17. Tanemoto M, Kittaka N, Inanobe A, Kurachi Y,. In vivo formation of a proton-sensitive K+ channel by heteromeric subunit assembly of Kir5.1 with Kir4.1. J Physiol 2000; 525 (pt 3): 587-592.
18. Bockenhauer D, Feather S, Stanescu HC, et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009; 360: 1960-1970.
19. Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-717.
20. Lassmann H,. Review: The architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis. Neuropathol Appl Neurobiol 2011; 37: 698-710.
21. Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130 (pt 4): 1089-1104.
22. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125 (pt 7): 1450-1461.
23. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
24. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007; 130 (pt 5): 1194-1205.
25. Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130 (pt 5): 1224-1234.
26. Kraus V, Srivastava R, Kalluri SR, et al. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease. Neurology 2014; 82: 470-473.
27. O'Connor KC, Appel H, Bregoli L, et al. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol 2005; 175: 1974-1982.
28. Kuhlmann T, Remington L, Maruschak B, et al. Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol 2007; 66: 238-246.
29. Menichella DM, Majdan M, Awatramani R, et al. Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J Neurosci 2006; 26: 10984-10991.
30. Butt AM, Kalsi A,. Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions. J Cell Mol Med 2006; 10: 33-44.
31. Bruck W, Porada P, Poser S, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995; 38: 788-796.
32. Han MH, Hwang SI, Roy DB, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008; 451: 1076-1081.
33. Schirmer L, Albert M, Buss A, et al. Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord. Ann Neurol 2009; 66: 698-704.
34. Barnett MH, Parratt JD, Cho ES, Prineas JW,. Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann Neurol 2009; 65: 32-46.
35. Prineas JW, Parratt JD,. Oligodendrocytes and the early multiple sclerosis lesion. Ann Neurol 2012; 72: 18-31.
36. Gheuens S, Wuthrich C, Koralnik IJ,. Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol 2013; 8: 189-215.
37. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013; 80: 1430-1438.
38. Young NP, Weinshenker BG, Parisi JE, et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain 2010; 133 (pt 2): 333-348.
39. Warth A, Mittelbronn M, Wolburg H,. Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumors. Acta Neuropathol 2005; 109: 418-426.
40. Lucchinetti CF, Guo Y, Popescu BF, et al. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 2014; 24: 83-97.
41. Vit JP, Ohara PT, Bhargava A, et al. Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury. J Neurosci 2008; 28: 4161-4171.
42. Rash JE,. Molecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system. Neuroscience 2010; 168: 982-1008.
43. Kuhlmann T, Miron V, Cui Q, et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008; 131 (pt 7): 1749-1758.
44. Hinson SR, Roemer SF, Lucchinetti CF, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008; 205: 2473-2481.
45. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010; 30: 5866-5875.
46. Chever O, Djukic B, McCarthy KD, Amzica F,. Implication of Kir4.1 channel in excess potassium clearance: an in vivo study on anesthetized glial-conditional Kir4.1 knock-out mice. J Neurosci 2010; 30: 15769-15777.
47. Kamasawa N, Sik A, Morita M, et al. Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning. Neuroscience 2005; 136: 65-86.
48. Markoullis K, Sargiannidou I, Schiza N, et al. Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol 2012; 123: 873-886.
49. Heuser K, Eid T, Lauritzen F, et al. Loss of perivascular Kir4.1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy. J Neuropathol Exp Neurol 2012; 71: 814-825.
50. Tong X, Ao Y, Faas GC, et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat Neurosci 2014; 17: 694-703.
51. Kaiser M, Maletzki I, Hulsmann S, et al. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 2006; 99: 900-912.
52. Olsen ML, Campbell SC, McFerrin MB, et al. Spinal cord injury causes a wide-spread, persistent loss of Kir4.1 and glutamate transporter 1: benefit of 17 beta-oestradiol treatment. Brain 2010; 133 (pt 4): 1013-1025.
53. Dibas A, Oku H, Fukuhara M, et al. Changes in ocular aquaporin expression following optic nerve crush. Mol Vis 2010; 16: 330-340.
54. Wang YF, Gu YT, Xu WB, Lv G,. Temporary loss of perivascular aquaporin-4 in white matter after the spinal cord ischemic injury of rats. Neuroreport 2009; 20: 145-149.
55. Parratt JD, Prineas JW,. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult Scler 2010; 16: 1156-1172.
56. Brosnan CF, Raine CS,. The astrocyte in multiple sclerosis revisited. Glia 2013; 61: 453-465.
57. Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009; 66: 630-643.
58. Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009; 66: 617-629.